Open access
Open access
Powered by Google Translator Translator

RCT: In children with relapsing steroid-sensitive nephrotic syndrome with acute respiratory tract infection, a daily low dose of prednisolone did not reduce the risk of relapse.

27 Jan, 2022 | 09:32h | UTC

Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial – JAMA Pediatrics

Commentary: PREDNOS 2: Prednisolone Doesn’t Lower Relapse Risks in Kids with Nephrotic Syndrome – Physician’s Weekly


Commentary on Twitter


Stay Updated in Your Specialty

No spam, just news.